Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 3
1997 2
1998 1
2000 4
2001 6
2002 5
2012 1
2016 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Gene therapy of severe combined immunodeficiencies.
Fischer A, Hacein-Bey S, Cavazzana-Calvo M. Fischer A, et al. Among authors: hacein bey s. Nat Rev Immunol. 2002 Aug;2(8):615-21. doi: 10.1038/nri859. Nat Rev Immunol. 2002. PMID: 12154380 Review.
[Gene therapy of hereditary immunologic deficiencies].
Fischer A, de Saint-Basile G, Disanto JP, Hacein-Bey S, Sharara L, Cavazzana-Calvo M. Fischer A, et al. Among authors: hacein bey s. Arch Pediatr. 1996;3 Suppl 1:69s-76s. doi: 10.1016/0929-693x(96)85997-5. Arch Pediatr. 1996. PMID: 8795972 Review. French. No abstract available.
Gene therapy of severe combined immunodeficiencies.
Fischer A, Hacein-Bey S, Le Deist F, Soudais C, Di Santo JP, de Saint Basile G, Cavazzana-Calvo M. Fischer A, et al. Among authors: hacein bey s. Immunol Rev. 2000 Dec;178:13-20. doi: 10.1034/j.1600-065x.2000.17806.x. Immunol Rev. 2000. PMID: 11213798 Review.
Gene therapy for human severe combined immunodeficiencies.
Fischer A, Hacein-Bey S, Le Deist F, de Saint Basile G, Cavazzana-Calvo M. Fischer A, et al. Among authors: hacein bey s. Isr Med Assoc J. 2002 Jan;4(1):51-4. Isr Med Assoc J. 2002. PMID: 11802313 Free article. Review. No abstract available.
Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M, Hacein-Bey S, Yates F, de Villartay JP, Le Deist F, Fischer A. Cavazzana-Calvo M, et al. Among authors: hacein bey s. J Gene Med. 2001 May-Jun;3(3):201-6. doi: 10.1002/1521-2254(200105/06)3:3<201::AID-JGM195>3.0.CO;2-Z. J Gene Med. 2001. PMID: 11437325 Review.
[Gene therapy of severe combined immunodeficiencies].
Cavazzana-Calvo M, Hacein-Bey S, de Saint-Basile G, Le Deist F, Fischer A. Cavazzana-Calvo M, et al. Among authors: hacein bey s. Transfus Clin Biol. 2000 Jun;7(3):259-60. Transfus Clin Biol. 2000. PMID: 10919216 Review. French. No abstract available.
Gene therapy for human severe combined immunodeficiencies.
Fischer A, Hacein-Bey S, Le Deist F, de Saint Basile G, Cavazzana-Calvo M. Fischer A, et al. Among authors: hacein bey s. Immunity. 2001 Jul;15(1):1-4. doi: 10.1016/s1074-7613(01)00175-3. Immunity. 2001. PMID: 11485732 Free article. Review. No abstract available.
Gene therapy of primary immunodeficiencies.
Fischer A, De Saint Basile G, Disanto JP, Hacein-Bey S, Sharara L, Cavazzana-Calvo M. Fischer A, et al. Among authors: hacein bey s. Adv Nephrol Necker Hosp. 1997;26:107-20. Adv Nephrol Necker Hosp. 1997. PMID: 8922128 Review. No abstract available.
Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice.
Nocturne G, Ly B, Paoletti A, Pascaud J, Seror R, Nicco C, Mackay F, Vincent FB, Lazure T, Ferlicot S, Stimmer L, Pascal Q, Roulland S, Krzysiek R, Hacein-Bey S, Batteux F, Mariette X. Nocturne G, et al. Among authors: hacein bey s. Clin Exp Immunol. 2021 Aug;205(2):169-181. doi: 10.1111/cei.13602. Epub 2021 May 30. Clin Exp Immunol. 2021. PMID: 33864242 Free PMC article.
26 results